Literature DB >> 1847160

Signal transduction via CD4, CD8, and CD28 in mature and immature thymocytes. Implications for thymic selection.

L A Turka1, P S Linsley, R Paine, G L Schieven, G B Thompson, J A Ledbetter.   

Abstract

The positive and negative selection of immature thymocytes that shapes the mature T cell repertoire appears to occur at an intermediate stage of development when the cells express low levels of TCR/CD3. These cells are also CD4+CD8+ and CD28+ (dull), and signals delivered by these three accessory molecules have been implicated in the selection process. We have examined the regulatory function of these accessory molecules on responses of immature thymocytes stimulated through the TCR/CD3 complex. Cross-linking CD4 or CD8 with CD3 strongly enhanced signal transduction via CD3 as assessed by protein tyrosine phosphorylation and calcium mobilization. Subsequent cell proliferation could be induced by soluble anti-CD28 mAb, which was comitogenic for cells stimulated with CD3 x CD4 or CD3 x CD8 cross-linking, but was without effect on cells stimulated with CD3 x CD3 cross-linking. A potential role for CD28 signal transduction in thymic maturation is suggested by the demonstration that the BB-1 molecule, a natural ligand for CD28, is expressed on thymic stromal cells. Taken together, our data suggest a model of thymic development in which CD4 or CD8 may enhance TCR/CD3 signaling upon coligation by an MHC molecule. If the CD28 surface receptor is simultaneously stimulated by a BB-1 expressing stromal cell, this set of interactions could lead to proliferation and positive selection. In the absence of CD28 stimulation the enhanced TCR/CD3 signals might lead to apoptosis and negative selection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847160

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.

Authors:  M Azuma; M Cayabyab; D Buck; J H Phillips; L L Lanier
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

2.  Defective signal transduction by the CD2 molecule in immature T-cell receptor/CD3- thymocytes.

Authors:  L A Turka; M C Fletcher; N Craighead; C B Thompson; C H June
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

3.  Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo.

Authors:  B J Nickoloff; R S Mitra; K Lee; L A Turka; J Green; C Thompson; Y Shimizu
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

4.  Enhancement of CD3-mediated thymocyte apoptosis by the cross-linkage of heat-stable antigen.

Authors:  Y Hitsumoto; D S Song; M Okada; F Hamada; S Saheki; N Takeuchi
Journal:  Immunology       Date:  1996-10       Impact factor: 7.397

5.  Data base analysis of protein expression patterns during T-cell ontogeny and activation.

Authors:  S M Hanash; J R Strahler; Y Chan; R Kuick; D Teichroew; J V Neel; N Hailat; D R Keim; J Gratiot-Deans; D Ungar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

6.  Maturation stage and proliferation-dependent expression of dUTPase in human T cells.

Authors:  J R Strahler; X X Zhu; N Hora; Y K Wang; P C Andrews; N A Roseman; J V Neel; L Turka; S M Hanash
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

7.  Human T-cell leukemia virus type I-induced proliferation of human immature CD2+CD3- thymocytes.

Authors:  V Maguer; H Cassé-Ripoll; L Gazzolo; M D Dodon
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

8.  Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.

Authors:  V A Boussiotis; G J Freeman; J G Gribben; J Daley; G Gray; L M Nadler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

9.  Anti-CD28 antibody- and IL-4-induced human T cell proliferation is sensitive to rapamycin.

Authors:  H Luo; H Chen; P Daloze; G St-Louis; J Wu
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

10.  Differential expression of Op18 phosphoprotein during human thymocyte maturation.

Authors:  J Gratiot-Deans; D Keim; J R Strahler; L A Turka; S Hanash
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.